STUDY OF MK-2118 ADMINISTERED AS INTRATUMORAL INJECTION AS MONOTHERAPY AND IN COMBINATION WITH PEMBROLIZUMAB (MK-3475) IN THE TREATMENT OF ADULTS WITH ADVANCED/METASTATIC SOLID TUMORS OR LYMPHOMAS (MK-2118-001):